![Amy Reilly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amy Reilly
Investor Relations Kontakt bei DYNE THERAPEUTICS, INC.
Aktive Positionen von Amy Reilly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DYNE THERAPEUTICS, INC. | Investor Relations Kontakt | 01.07.2020 | - |
Public Communications Contact | 01.07.2020 | - |
Karriereverlauf von Amy Reilly
Ehemalige bekannte Positionen von Amy Reilly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KALEIDO BIOSCIENCES, INC. | Investor Relations Kontakt | 01.09.2018 | 01.05.2020 |
Public Communications Contact | 01.11.2017 | 01.05.2020 | |
THERMO FISHER SCIENTIFIC | Public Communications Contact | 01.03.2017 | 01.10.2017 |
IMMUNOGEN, INC. | Public Communications Contact | 01.10.2015 | 01.03.2017 |
CUBIST PHARMACEUTICALS INC | Public Communications Contact | 01.01.2011 | 01.01.2015 |
Ausbildung von Amy Reilly
Bowdoin College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Public Communications Contact | 5 |
Investor Relations Contact | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
KALEIDO BIOSCIENCES, INC. | Health Technology |
DYNE THERAPEUTICS, INC. | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
Private Unternehmen | 2 |
---|---|
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
ImmunoGen, Inc.
![]() ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Amy Reilly
- Erfahrung